Dendritic cell vaccines for high-grade gliomas Article Swipe
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.2147/tcrm.s135865
Glioblastoma (GBM) is the most common and fatal primary adult brain tumor. To date, various promising chemotherapeutic regimens have been trialed for use in GBM; however, temozolomide (TMZ) therapy remains the only US Food and Drug Administration-approved first-line chemotherapeutic option for newly diagnosed GBM. Despite maximal therapy with surgery and combined concurrent chemoradiation and adjuvant TMZ therapy, the median overall survival remains approximately 14 months. Given the failure of conventional chemotherapeutic strategies in GBM, there has been renewed interest in the role of immunotherapy in GBM. Dendritic cells are immune antigen-presenting cells that play a role in both the innate and adaptive immune system, thereby making them prime vehicles for immunotherapy via dendritic cell vaccinations (DCVs) in various cancers. There is great enthusiasm surrounding the use of DCVs for GBM with multiple ongoing trials. In this review, we comprehensively summarize the safety, efficacy, and quality of life results from 33 trials reporting on DCV for high-grade gliomas.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.2147/tcrm.s135865
- https://www.dovepress.com/getfile.php?fileID=43329
- OA Status
- gold
- Cited By
- 53
- References
- 104
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2883891816
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2883891816Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2147/tcrm.s135865Digital Object Identifier
- Title
-
Dendritic cell vaccines for high-grade gliomasWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-07-01Full publication date if available
- Authors
-
Matthew E. Eagles, Farshad Nassiri, Jetan H. Badhiwala, Suganth Suppiah, Saleh A. Almenawer, Gelareh Zadeh, Kenneth AldapeList of authors in order
- Landing page
-
https://doi.org/10.2147/tcrm.s135865Publisher landing page
- PDF URL
-
https://www.dovepress.com/getfile.php?fileID=43329Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.dovepress.com/getfile.php?fileID=43329Direct OA link when available
- Concepts
-
Medicine, Temozolomide, Adjuvant, Immunotherapy, Glioma, Dendritic cell, Immune system, Oncology, Internal medicine, Cancer research, ImmunologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
53Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 4, 2023: 12, 2022: 13, 2021: 9Per-year citation counts (last 5 years)
- References (count)
-
104Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2883891816 |
|---|---|
| doi | https://doi.org/10.2147/tcrm.s135865 |
| ids.doi | https://doi.org/10.2147/tcrm.s135865 |
| ids.mag | 2883891816 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30100728 |
| ids.openalex | https://openalex.org/W2883891816 |
| fwci | 2.67252388 |
| type | review |
| title | Dendritic cell vaccines for high-grade gliomas |
| biblio.issue | |
| biblio.volume | Volume 14 |
| biblio.last_page | 1313 |
| biblio.first_page | 1299 |
| topics[0].id | https://openalex.org/T10580 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immunotherapy and Immune Responses |
| topics[1].id | https://openalex.org/T10129 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9983999729156494 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2716 |
| topics[1].subfield.display_name | Genetics |
| topics[1].display_name | Glioma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9980999827384949 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list.value | 2836 |
| apc_list.currency | USD |
| apc_list.value_usd | 2836 |
| apc_paid.value | 2836 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2836 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8972010612487793 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777389519 |
| concepts[1].level | 3 |
| concepts[1].score | 0.892565131187439 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q425088 |
| concepts[1].display_name | Temozolomide |
| concepts[2].id | https://openalex.org/C2777863537 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7107506394386292 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q357896 |
| concepts[2].display_name | Adjuvant |
| concepts[3].id | https://openalex.org/C2777701055 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6278848052024841 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[3].display_name | Immunotherapy |
| concepts[4].id | https://openalex.org/C2778227246 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5887450575828552 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1365309 |
| concepts[4].display_name | Glioma |
| concepts[5].id | https://openalex.org/C2778170410 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5140810608863831 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q506253 |
| concepts[5].display_name | Dendritic cell |
| concepts[6].id | https://openalex.org/C8891405 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4998197555541992 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[6].display_name | Immune system |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4788748621940613 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3486858606338501 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C502942594 |
| concepts[9].level | 1 |
| concepts[9].score | 0.34856611490249634 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[9].display_name | Cancer research |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.28825733065605164 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8972010612487793 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/temozolomide |
| keywords[1].score | 0.892565131187439 |
| keywords[1].display_name | Temozolomide |
| keywords[2].id | https://openalex.org/keywords/adjuvant |
| keywords[2].score | 0.7107506394386292 |
| keywords[2].display_name | Adjuvant |
| keywords[3].id | https://openalex.org/keywords/immunotherapy |
| keywords[3].score | 0.6278848052024841 |
| keywords[3].display_name | Immunotherapy |
| keywords[4].id | https://openalex.org/keywords/glioma |
| keywords[4].score | 0.5887450575828552 |
| keywords[4].display_name | Glioma |
| keywords[5].id | https://openalex.org/keywords/dendritic-cell |
| keywords[5].score | 0.5140810608863831 |
| keywords[5].display_name | Dendritic cell |
| keywords[6].id | https://openalex.org/keywords/immune-system |
| keywords[6].score | 0.4998197555541992 |
| keywords[6].display_name | Immune system |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.4788748621940613 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.3486858606338501 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/cancer-research |
| keywords[9].score | 0.34856611490249634 |
| keywords[9].display_name | Cancer research |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.28825733065605164 |
| keywords[10].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.2147/tcrm.s135865 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S204453222 |
| locations[0].source.issn | 1176-6336, 1178-203X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1176-6336 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Therapeutics and Clinical Risk Management |
| locations[0].source.host_organization | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_name | Dove Medical Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320348 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://www.dovepress.com/getfile.php?fileID=43329 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Therapeutics and Clinical Risk Management |
| locations[0].landing_page_url | https://doi.org/10.2147/tcrm.s135865 |
| locations[1].id | pmid:30100728 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Therapeutics and clinical risk management |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30100728 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:6067774 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Ther Clin Risk Manag |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6067774 |
| locations[3].id | pmh:oai:europepmc.org:5033976 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | http://europepmc.org/pmc/articles/PMC6067774 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5073674405 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2585-7230 |
| authorships[0].author.display_name | Matthew E. Eagles |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I168635309 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; |
| authorships[0].affiliations[1].raw_affiliation_string | Section of Neurosurgery, |
| authorships[0].institutions[0].id | https://openalex.org/I168635309 |
| authorships[0].institutions[0].ror | https://ror.org/03yjb2x39 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I168635309 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | University of Calgary |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Matthew Eagles |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada;, Section of Neurosurgery, |
| authorships[1].author.id | https://openalex.org/A5007013927 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0797-3425 |
| authorships[1].author.display_name | Farshad Nassiri |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1325899441 |
| authorships[1].affiliations[0].raw_affiliation_string | MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I185261750 |
| authorships[1].affiliations[1].raw_affiliation_string | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; |
| authorships[1].institutions[0].id | https://openalex.org/I1325899441 |
| authorships[1].institutions[0].ror | https://ror.org/042xt5161 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1325899441 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | University Health Network |
| authorships[1].institutions[1].id | https://openalex.org/I185261750 |
| authorships[1].institutions[1].ror | https://ror.org/03dbr7087 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I185261750 |
| authorships[1].institutions[1].country_code | CA |
| authorships[1].institutions[1].display_name | University of Toronto |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Farshad Nassiri |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada;, MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| authorships[2].author.id | https://openalex.org/A5077943043 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2528-1684 |
| authorships[2].author.display_name | Jetan H. Badhiwala |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I185261750 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; |
| authorships[2].institutions[0].id | https://openalex.org/I185261750 |
| authorships[2].institutions[0].ror | https://ror.org/03dbr7087 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I185261750 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | University of Toronto |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jetan Badhiwala |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; |
| authorships[3].author.id | https://openalex.org/A5063162459 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4569-0466 |
| authorships[3].author.display_name | Suganth Suppiah |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I185261750 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; |
| authorships[3].institutions[0].id | https://openalex.org/I185261750 |
| authorships[3].institutions[0].ror | https://ror.org/03dbr7087 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I185261750 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | University of Toronto |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Suganth Suppiah |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; |
| authorships[4].author.id | https://openalex.org/A5009867273 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Saleh A. Almenawer |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I98251732 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Surgery, McMaster University, Hamilton, ON, Canada; |
| authorships[4].affiliations[1].raw_affiliation_string | Division of Neurosurgery, |
| authorships[4].institutions[0].id | https://openalex.org/I98251732 |
| authorships[4].institutions[0].ror | https://ror.org/02fa3aq29 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I98251732 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | McMaster University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Saleh Almenawer |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Surgery, McMaster University, Hamilton, ON, Canada;, Division of Neurosurgery, |
| authorships[5].author.id | https://openalex.org/A5072584423 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6637-4502 |
| authorships[5].author.display_name | Gelareh Zadeh |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1325899441 |
| authorships[5].affiliations[0].raw_affiliation_string | MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I1325899441 |
| authorships[5].affiliations[1].raw_affiliation_string | Division of Neurosurgery, University Health Network, Toronto, ON, Canada; |
| authorships[5].institutions[0].id | https://openalex.org/I1325899441 |
| authorships[5].institutions[0].ror | https://ror.org/042xt5161 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1325899441 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | University Health Network |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Gelareh Zadeh |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Neurosurgery, University Health Network, Toronto, ON, Canada;, MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| authorships[6].author.id | https://openalex.org/A5063290790 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5119-7550 |
| authorships[6].author.display_name | Kenneth Aldape |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1325899441 |
| authorships[6].affiliations[0].raw_affiliation_string | Division of Pathology, University Health Network, Toronto, ON, Canada |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I1325899441 |
| authorships[6].affiliations[1].raw_affiliation_string | MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| authorships[6].institutions[0].id | https://openalex.org/I1325899441 |
| authorships[6].institutions[0].ror | https://ror.org/042xt5161 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I1325899441 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | University Health Network |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Kenneth Aldape |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Division of Pathology, University Health Network, Toronto, ON, Canada, MacFeeters-Hamilton Neuro-Oncology Program, University Health Network, Toronto, ON, Canada; |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.dovepress.com/getfile.php?fileID=43329 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Dendritic cell vaccines for high-grade gliomas |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10580 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immunotherapy and Immune Responses |
| related_works | https://openalex.org/W2235074116, https://openalex.org/W2123602693, https://openalex.org/W2389962403, https://openalex.org/W3031084637, https://openalex.org/W2136925073, https://openalex.org/W137690307, https://openalex.org/W2073671804, https://openalex.org/W110876028, https://openalex.org/W2023907037, https://openalex.org/W2372050649 |
| cited_by_count | 53 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 12 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 13 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 9 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 9 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 3 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.2147/tcrm.s135865 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S204453222 |
| best_oa_location.source.issn | 1176-6336, 1178-203X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1176-6336 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Therapeutics and Clinical Risk Management |
| best_oa_location.source.host_organization | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_name | Dove Medical Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=43329 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Therapeutics and Clinical Risk Management |
| best_oa_location.landing_page_url | https://doi.org/10.2147/tcrm.s135865 |
| primary_location.id | doi:10.2147/tcrm.s135865 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S204453222 |
| primary_location.source.issn | 1176-6336, 1178-203X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1176-6336 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Therapeutics and Clinical Risk Management |
| primary_location.source.host_organization | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_name | Dove Medical Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://www.dovepress.com/getfile.php?fileID=43329 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Therapeutics and Clinical Risk Management |
| primary_location.landing_page_url | https://doi.org/10.2147/tcrm.s135865 |
| publication_date | 2018-07-01 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W1560814177, https://openalex.org/W2148977460, https://openalex.org/W2555013339, https://openalex.org/W2159661815, https://openalex.org/W2096287682, https://openalex.org/W2095715696, https://openalex.org/W2147482980, https://openalex.org/W7075739504, https://openalex.org/W2127982431, https://openalex.org/W7073986165, https://openalex.org/W2562815599, https://openalex.org/W2417756087, https://openalex.org/W2043904711, https://openalex.org/W1992699637, https://openalex.org/W2062448230, https://openalex.org/W1594958193, https://openalex.org/W2077468106, https://openalex.org/W2013090484, https://openalex.org/W2156327992, https://openalex.org/W2114701172, https://openalex.org/W1891618255, https://openalex.org/W2115961668, https://openalex.org/W2097882623, https://openalex.org/W2486542402, https://openalex.org/W7073547506, https://openalex.org/W2134007339, https://openalex.org/W2103959341, https://openalex.org/W1989207092, https://openalex.org/W2166112009, https://openalex.org/W1893588436, https://openalex.org/W2144616410, https://openalex.org/W2075180002, https://openalex.org/W2098263349, https://openalex.org/W2162630386, https://openalex.org/W2166637991, https://openalex.org/W2123909650, https://openalex.org/W2117735567, https://openalex.org/W2155367074, https://openalex.org/W2141099036, https://openalex.org/W2135811373, https://openalex.org/W2128961069, https://openalex.org/W2107098070, https://openalex.org/W1987131997, https://openalex.org/W2606625852, https://openalex.org/W2613340520, https://openalex.org/W2612580348, https://openalex.org/W2112724852, https://openalex.org/W2167571044, https://openalex.org/W2097995306, https://openalex.org/W7075602201, https://openalex.org/W2118982164, https://openalex.org/W1982488143, https://openalex.org/W6673817323, https://openalex.org/W6653295237, https://openalex.org/W2159059319, https://openalex.org/W1848890174, https://openalex.org/W2090454492, https://openalex.org/W2013637325, https://openalex.org/W1995024447, https://openalex.org/W2572174216, https://openalex.org/W4211107967, https://openalex.org/W4233099643, https://openalex.org/W2133499518, https://openalex.org/W2036044314, https://openalex.org/W2143523733, https://openalex.org/W2029882097, https://openalex.org/W1537392447, https://openalex.org/W2072838309, https://openalex.org/W2148584717, https://openalex.org/W2005651129, https://openalex.org/W2328946792, https://openalex.org/W2091753499, https://openalex.org/W2093404265, https://openalex.org/W4251277328, https://openalex.org/W2080869340, https://openalex.org/W2050216284, https://openalex.org/W2010790611, https://openalex.org/W2096555449, https://openalex.org/W2137405984, https://openalex.org/W2126200259, https://openalex.org/W2035934652, https://openalex.org/W2020604769, https://openalex.org/W2026938154, https://openalex.org/W2100004531, https://openalex.org/W2022976025, https://openalex.org/W2093373625, https://openalex.org/W1996398553, https://openalex.org/W2066671159, https://openalex.org/W2008519462, https://openalex.org/W4237383393, https://openalex.org/W2051361937, https://openalex.org/W2560367415, https://openalex.org/W2105100844, https://openalex.org/W2044835625, https://openalex.org/W1983539927, https://openalex.org/W4245392732, https://openalex.org/W2160382843, https://openalex.org/W2128035403, https://openalex.org/W2624094894, https://openalex.org/W2073139940, https://openalex.org/W2327897736, https://openalex.org/W2093040850, https://openalex.org/W4293529598, https://openalex.org/W2332922232 |
| referenced_works_count | 104 |
| abstract_inverted_index.a | 94 |
| abstract_inverted_index.14 | 63 |
| abstract_inverted_index.33 | 149 |
| abstract_inverted_index.In | 134 |
| abstract_inverted_index.To | 12 |
| abstract_inverted_index.US | 32 |
| abstract_inverted_index.in | 23, 72, 79, 84, 96, 116 |
| abstract_inverted_index.is | 2, 120 |
| abstract_inverted_index.of | 68, 82, 126, 145 |
| abstract_inverted_index.on | 152 |
| abstract_inverted_index.we | 137 |
| abstract_inverted_index.DCV | 153 |
| abstract_inverted_index.GBM | 129 |
| abstract_inverted_index.TMZ | 55 |
| abstract_inverted_index.and | 6, 34, 49, 53, 100, 143 |
| abstract_inverted_index.are | 88 |
| abstract_inverted_index.for | 21, 40, 109, 128, 154 |
| abstract_inverted_index.has | 75 |
| abstract_inverted_index.the | 3, 30, 57, 66, 80, 98, 124, 140 |
| abstract_inverted_index.use | 22, 125 |
| abstract_inverted_index.via | 111 |
| abstract_inverted_index.DCVs | 127 |
| abstract_inverted_index.Drug | 35 |
| abstract_inverted_index.Food | 33 |
| abstract_inverted_index.GBM, | 73 |
| abstract_inverted_index.GBM. | 43, 85 |
| abstract_inverted_index.GBM; | 24 |
| abstract_inverted_index.been | 19, 76 |
| abstract_inverted_index.both | 97 |
| abstract_inverted_index.cell | 113 |
| abstract_inverted_index.from | 148 |
| abstract_inverted_index.have | 18 |
| abstract_inverted_index.life | 146 |
| abstract_inverted_index.most | 4 |
| abstract_inverted_index.only | 31 |
| abstract_inverted_index.play | 93 |
| abstract_inverted_index.role | 81, 95 |
| abstract_inverted_index.that | 92 |
| abstract_inverted_index.them | 106 |
| abstract_inverted_index.this | 135 |
| abstract_inverted_index.with | 47, 130 |
| abstract_inverted_index.(GBM) | 1 |
| abstract_inverted_index.(TMZ) | 27 |
| abstract_inverted_index.Given | 65 |
| abstract_inverted_index.There | 119 |
| abstract_inverted_index.adult | 9 |
| abstract_inverted_index.brain | 10 |
| abstract_inverted_index.cells | 87, 91 |
| abstract_inverted_index.date, | 13 |
| abstract_inverted_index.fatal | 7 |
| abstract_inverted_index.great | 121 |
| abstract_inverted_index.newly | 41 |
| abstract_inverted_index.prime | 107 |
| abstract_inverted_index.there | 74 |
| abstract_inverted_index.(DCVs) | 115 |
| abstract_inverted_index.common | 5 |
| abstract_inverted_index.immune | 89, 102 |
| abstract_inverted_index.innate | 99 |
| abstract_inverted_index.making | 105 |
| abstract_inverted_index.median | 58 |
| abstract_inverted_index.option | 39 |
| abstract_inverted_index.trials | 150 |
| abstract_inverted_index.tumor. | 11 |
| abstract_inverted_index.Despite | 44 |
| abstract_inverted_index.failure | 67 |
| abstract_inverted_index.maximal | 45 |
| abstract_inverted_index.months. | 64 |
| abstract_inverted_index.ongoing | 132 |
| abstract_inverted_index.overall | 59 |
| abstract_inverted_index.primary | 8 |
| abstract_inverted_index.quality | 144 |
| abstract_inverted_index.remains | 29, 61 |
| abstract_inverted_index.renewed | 77 |
| abstract_inverted_index.results | 147 |
| abstract_inverted_index.review, | 136 |
| abstract_inverted_index.safety, | 141 |
| abstract_inverted_index.surgery | 48 |
| abstract_inverted_index.system, | 103 |
| abstract_inverted_index.therapy | 28, 46 |
| abstract_inverted_index.thereby | 104 |
| abstract_inverted_index.trialed | 20 |
| abstract_inverted_index.trials. | 133 |
| abstract_inverted_index.various | 14, 117 |
| abstract_inverted_index.adaptive | 101 |
| abstract_inverted_index.adjuvant | 54 |
| abstract_inverted_index.cancers. | 118 |
| abstract_inverted_index.combined | 50 |
| abstract_inverted_index.gliomas. | 156 |
| abstract_inverted_index.however, | 25 |
| abstract_inverted_index.interest | 78 |
| abstract_inverted_index.multiple | 131 |
| abstract_inverted_index.regimens | 17 |
| abstract_inverted_index.survival | 60 |
| abstract_inverted_index.therapy, | 56 |
| abstract_inverted_index.vehicles | 108 |
| abstract_inverted_index.Dendritic | 86 |
| abstract_inverted_index.dendritic | 112 |
| abstract_inverted_index.diagnosed | 42 |
| abstract_inverted_index.efficacy, | 142 |
| abstract_inverted_index.promising | 15 |
| abstract_inverted_index.reporting | 151 |
| abstract_inverted_index.summarize | 139 |
| abstract_inverted_index.concurrent | 51 |
| abstract_inverted_index.enthusiasm | 122 |
| abstract_inverted_index.first-line | 37 |
| abstract_inverted_index.high-grade | 155 |
| abstract_inverted_index.strategies | 71 |
| abstract_inverted_index.surrounding | 123 |
| abstract_inverted_index.Glioblastoma | 0 |
| abstract_inverted_index.conventional | 69 |
| abstract_inverted_index.temozolomide | 26 |
| abstract_inverted_index.vaccinations | 114 |
| abstract_inverted_index.approximately | 62 |
| abstract_inverted_index.immunotherapy | 83, 110 |
| abstract_inverted_index.chemoradiation | 52 |
| abstract_inverted_index.comprehensively | 138 |
| abstract_inverted_index.chemotherapeutic | 16, 38, 70 |
| abstract_inverted_index.antigen-presenting | 90 |
| abstract_inverted_index.Administration-approved | 36 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.550000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.87432737 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |